SCM
NUVB icon

Sterling Capital Management’s Nuvation Bio NUVB Stock Holding History

Sterling Capital Management’s Portfolio NUVB Stock Details NUVB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.03K Sell
885
-6,601
-88% -$32.3K ﹤0.01% 2609
2026
Q1 		$32.1K Sell
7,486
-5,443
-42% -$30.3K ﹤0.01% 1816
2025
Q4 		$116K Sell
12,929
-2,973
-19% -$18.4K ﹤0.01% 1475
2025
Q3 		$58.8K Buy
15,902
+9,650
+154% +$26.3K ﹤0.01% 1707
2025
Q2 		$12.2K Buy
6,252
+3,124
+100% +$6.51K ﹤0.01% 2004
2025
Q1 		$5.5K Sell
3,128
-2,679
-46% -$6.1K ﹤0.01% 2120
2024
Q4 		$15.4K Buy
5,807
+5,180
+826% +$13.3K ﹤0.01% 1960
2024
Q3 		$1.44K Buy
+627
New +$1.91K ﹤0.01% 2357

Other funds holding NUVB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DC
Decheng Capital Menlo Park, California $732M AUM 275.56% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
OFM
Omega Fund Management Boston, Massachusetts $186M AUM 155.23% 1-Year Est. Return
LCM
Laurion Capital Management New York $3.9B AUM 75.03% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
DFO
Duquesne Family Office New York $5.21B AUM 87.01% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Sterling Capital Management's NUVB Position: Q2 2026 in Review

Sterling Capital Management reduced its Nuvation Bio (NUVB) stake by 88% in Q2 2026, selling an estimated $32.3K and leaving 885 shares worth $5.03K. The position accounts for ﹤0.01% of the portfolio, ranked #2609.

Sterling Capital Management first reported a position in NUVB in Q3 2024 and has held it in 8 quarters since. The position peaked at $116K in Q4 2025. 244 funds tracked by Wall St. Rank hold NUVB as of Q2 2026.

  • Sterling Capital Management held 885 shares of Nuvation Bio worth $5.03K as of Q2 2026.
  • Sterling Capital Management sold 6,601 Nuvation Bio shares in Q2 2026, an estimated $32.3K.
  • Nuvation Bio made up ﹤0.01% of Sterling Capital Management's portfolio in Q2 2026, its #2609 holding.
  • Sterling Capital Management first reported a position in Nuvation Bio in Q3 2024 and has held it in 8 quarters since.
  • Sterling Capital Management's Nuvation Bio position peaked at $116K in Q4 2025.
  • 244 funds tracked by Wall St. Rank held Nuvation Bio as of Q2 2026.

Based on Sterling Capital Management's 13F filing for Q2 2026, filed 28 Jul 2026.